Healthy Volunteers Clinical Trial
Official title:
Communicating Multiple Disease Risks: A Translation of Risk Prediction Science
| Verified date | January 2020 |
| Source | Washington University School of Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Epidemiology seeks to improve public health by identifying risk factors for cancer and other
diseases and conveying that information to relevant audiences (e.g., physicians, the public).
The audience is presumed to understand and use that information to make appropriate decisions
about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can
affect the risk of multiple health outcomes, this information is seldom communicated to
people in a way that optimizes their understanding of the importance of engaging in a single
healthy behavior. Providing individuals with the ability to understand how a single behavior
(obtaining sufficient physical activity) could affect their risk of developing multiple
diseases could foster a more coherent and meaningful picture of the behavior's importance in
reducing health risks, increase motivation and intentions to engage in the behavior, and over
time improve public health.
The proposed study translates epidemiological data about five diseases that cause significant
morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes,
and stroke) into a visual display that conveys individualized risk estimates in a
comprehensible, meaningful, and useful way to diverse lay audiences.
| Status | Completed |
| Enrollment | 554 |
| Est. completion date | January 3, 2019 |
| Est. primary completion date | January 3, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 30 Years to 64 Years |
| Eligibility |
Inclusion Criteria: - 30-64 years of age - Less than (3) relevant comorbidities (diabetes, heart disease, stroke, and cancer, where cancer counts as (2) comorbidities for women but (1) for men) - Having a SMS capable mobile phone that is not shared with anyone else Exclusion Criteria: - Not meeting national guidelines for aerobic physical activity (i.e., at least 150 minutes per week of moderate intensity aerobic physical activity) - Participants from HRPO# 201501028 will be ineligible for this study - Uses text messaging less than once per month |
| Country | Name | City | State |
|---|---|---|---|
| United States | Washington University School of Medicine | Saint Louis | Missouri |
| Lead Sponsor | Collaborator |
|---|---|
| Washington University School of Medicine | National Cancer Institute (NCI), National Institutes of Health (NIH) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change From Baseline to 90-day Follow-up in Self Reported Weekly Minutes of Exercise | Baseline and up to 90 days | ||
| Primary | Difference in Gist Comprehension of Risk Information by Risk Display Format | Risk display format = risk ladder, table, or text Gist comprehension of risk information: being able to extract the bottom-line meaning of information provided by the website (e.g., if exercising decreased heath risk) Measured by the sum of (4) questions coded as correctly comprehending risk information (1 point) or incorrectly comprehending risk information (0 points), with a total score range of 0=low comprehension to 4=high comprehension. Higher comprehension is considered a better outcome. All comprehension questions have an additional "don't know" option, which is counted as incorrect. To limit participant burden, the investigators assessed comprehension for diabetes only, instead of all diseases as planned. Comprehension will not be assessed for people who report a history of diabetes because they are not given risk information. |
Baseline | |
| Primary | Difference in Verbatim Comprehension of Risk Information by Risk Communication Strategy | Risk communication strategy = risk ladder, table, or text Verbatim comprehension of risk information: being able to recall the exact information specific to diabetes risk and hours of recommended weekly physical activity Measured by the sum of (3) questions coded as correctly comprehending information (1 point) or incorrectly comprehending information (0 points), with a total score range of 0=low comprehension to 3=high comprehension. Higher comprehension is considered a better outcome. All comprehension questions have an additional "don't know" option, which is counted as incorrect. To limit participant burden, the investigators assessed comprehension for diabetes only, instead of all diseases as planned. Comprehension will not be assessed for people who report a history of diabetes because they are not given risk information. |
Baseline | |
| Primary | Difference in Self-reported Intentions to Engage in Physical Activity by Risk Display Format | Risk display format = risk ladder, table, or text Self-reported physical activity intentions is defined as intentions to engage in physical activity in the next 3 months Measured as an average of three variables, each measured on a 5 point Likert Scale (range: 1=lower intentions to 5=higher intentions) Higher intentions are considered a better outcome |
Baseline | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Maintenance Self-efficacy | Maintenance Self-efficacy is defined as being sure one can engage in physical activity even when it is hard Measured on a 4 point Likert Scale (range: 1=lower Maintenance Self-efficacy to 4=higher Maintenance Self-efficacy) Higher maintenance self-efficacy is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Recovery Self-efficacy | Recovery Self-efficacy is defined as being sure one can re-engage in physical activity after putting it off Measured on a 4 point Likert Scale (range: 1=lower recovery Self-efficacy to 4=higher recovery Self-efficacy) Higher recovery self-efficacy is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Enjoying Behavior | Affective Attitudes to Exercise - Enjoying Behavior is defined as thinking getting regular exercise is enjoyable Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise) Higher Affective Attitudes to Exercise - Enjoying Behavior is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Affective Attitudes to Exercise - Thinking Behavior is Unpleasant | Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is defined as not thinking getting regular exercise is unpleasant Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise) Higher Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Perceived Vividness of Self-regulatory Imagery | Perceived Vividness of Self-regulatory Imagery is defined as having clear and vivid images of steps towards getting physical activity Measured as an average of two variables measured on a 4 point Likert Scale (range: 1=lower Perceived Vividness of Self-regulatory Imagery to 4=higher Perceived Vividness of Self-regulatory Imagery) Higher Perceived Vividness of Self-regulatory Imagery is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Action Planning | Action planning is defined as having a detailed plan about getting adequate physical activity Measured as an average of three variables measured on a 4 point Likert Scale (range: 1=lower action planning to 4=higher action planning) Higher action planning is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Coping Planning | Coping planning is defined as having a detailed plan of solving problems that may prevent getting adequate physical activity Measured on a 4 point Likert Scale (range: 1=lower Coping Planning to 4=higher Coping Planning) Higher coping planning is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days | |
| Secondary | Effect of the Intervention on Physical Activity Levels as Measured by Action Self-efficacy | Action self-efficacy is defined as having the confidence to engage in physical activity Measured on a 4 point Likert Scale (range: 1=lower Action Self-efficacy to 4=higher Action Self-efficacy) Higher Action Self-efficacy is considered a better outcome Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items |
90 days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |